Clinical Trial Update: Proof-of-concept Study of New Imaging Diagnostic in Patients With Suspected Alzheimer's Disease [Phase 1]

View source ↗

Summary

A Phase 1 proof-of-concept study evaluating a new imaging diagnostic for suspected Alzheimer's disease has been terminated. The trial was conducted by Alzeca Bi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Alzeca Biosciences, Inc. | Conditions: Alzheimer Disease | Phase 1 | Status: TERMINATED